Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Return on Assets (2021 - 2025)

Tango Therapeutics has reported Return on Assets over the past 5 years, most recently at 0.33% for Q4 2025.

  • Quarterly results put Return on Assets at 0.33% for Q4 2025, up 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.33% (up 6.0% YoY), and the annual figure for FY2025 was 0.28%, up 8.0%.
  • Return on Assets for Q4 2025 was 0.33% at Tango Therapeutics, up from 0.45% in the prior quarter.
  • Over the last five years, Return on Assets for TNGX hit a ceiling of 0.1% in Q3 2021 and a floor of 0.57% in Q2 2025.
  • Median Return on Assets over the past 5 years was 0.26% (2021), compared with a mean of 0.28%.
  • Biggest five-year swings in Return on Assets: increased 6bps in 2022 and later decreased -27bps in 2025.
  • Tango Therapeutics' Return on Assets stood at 0.11% in 2021, then crashed by -112bps to 0.24% in 2022, then fell by -2bps to 0.24% in 2023, then plummeted by -59bps to 0.39% in 2024, then increased by 14bps to 0.33% in 2025.
  • The last three reported values for Return on Assets were 0.33% (Q4 2025), 0.45% (Q3 2025), and 0.57% (Q2 2025) per Business Quant data.